AB33. Botox: the novel therapy for OAB

Botulinum toxin has recently been approved by the United States FDA for idiopathic and neurogenic detrusor overactivity (overactive bladder). This is an easy clinic procedure that can be performed cystoscopically under local anesthesia with very good success. We will discuss the mechanism of action...

Descripción completa

Detalles Bibliográficos
Autor principal: Deng, Donna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2014
Materias:
Podium Lecture
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708434/
http://dx.doi.org/10.3978/j.issn.2223-4683.2014.s033
Descripción
Sumario:Botulinum toxin has recently been approved by the United States FDA for idiopathic and neurogenic detrusor overactivity (overactive bladder). This is an easy clinic procedure that can be performed cystoscopically under local anesthesia with very good success. We will discuss the mechanism of action of this drug, the efficacy, and clinical precautions to ensure a safe and successful result for the patient.

Ejemplares similares